These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 19721068)

  • 1. Development of NS3/4A protease-based reporter assay suitable for efficiently assessing hepatitis C virus infection.
    Pan KL; Lee JC; Sung HW; Chang TY; Hsu JT
    Antimicrob Agents Chemother; 2009 Nov; 53(11):4825-34. PubMed ID: 19721068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A reporter-based assay for identifying hepatitis C virus inhibitors based on subgenomic replicon cells.
    Lee JC; Chang CF; Chi YH; Hwang DR; Hsu JT
    J Virol Methods; 2004 Mar; 116(1):27-33. PubMed ID: 14715304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-throughput cell-based screening for hepatitis C virus NS3/4A protease inhibitors.
    Lee JC; Yu MC; Lien TW; Chang CF; Hsu JT
    Assay Drug Dev Technol; 2005 Aug; 3(4):385-92. PubMed ID: 16180993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a cell-based assay for monitoring specific hepatitis C virus NS3/4A protease activity in mammalian cells.
    Lee JC; Shih YF; Hsu SP; Chang TY; Chen LH; Hsu JT
    Anal Biochem; 2003 May; 316(2):162-70. PubMed ID: 12711336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A reporter cell line for rapid and sensitive evaluation of hepatitis C virus infectivity and replication.
    Iro M; Witteveldt J; Angus AG; Woerz I; Kaul A; Bartenschlager R; Patel AH
    Antiviral Res; 2009 Aug; 83(2):148-55. PubMed ID: 19397930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reporter substrates for assessing the activity of the hepatitis C virus NS3-4A serine protease in living cells.
    Pacini L; Bartholomew L; Vitelli A; Migliaccio G
    Anal Biochem; 2004 Aug; 331(1):46-59. PubMed ID: 15245996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo assay for hepatitis C viral serine protease activity using a secreted protein.
    Cho YG; Yang SH; Sung YC
    J Virol Methods; 1998 May; 72(1):109-15. PubMed ID: 9672138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening compounds against HCV based on MAVS/IFN-β pathway in a replicon model.
    Fu QX; Wang LC; Jia SZ; Gao B; Zhou Y; Du J; Wang YL; Wang XH; Peng JC; Zhan LS
    World J Gastroenterol; 2010 Nov; 16(44):5582-7. PubMed ID: 21105190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for hepatitis C virus antiviral activity with a cell-based secreted alkaline phosphatase reporter replicon system.
    Bourne N; Pyles RB; Yi M; Veselenak RL; Davis MM; Lemon SM
    Antiviral Res; 2005 Aug; 67(2):76-82. PubMed ID: 15927278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protease Inhibitors Block Multiple Functions of the NS3/4A Protease-Helicase during the Hepatitis C Virus Life Cycle.
    McGivern DR; Masaki T; Lovell W; Hamlett C; Saalau-Bethell S; Graham B
    J Virol; 2015 May; 89(10):5362-70. PubMed ID: 25740995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Establishment and the significance of a cell model of secreted alkaline phosphatase co-controlled by HCV 5'NCR and NS3 serine protease].
    Liu SP; Tan DM; Yang YF; Hou ZH
    Zhonghua Gan Zang Bing Za Zhi; 2004 Sep; 12(9):552-3. PubMed ID: 15387910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of vaniprevir, a hepatitis C virus NS3/4A protease inhibitor, in patients with HCV genotype 1 infection: safety, antiviral activity, resistance, and pharmacokinetics.
    Lawitz E; Sulkowski M; Jacobson I; Kraft WK; Maliakkal B; Al-Ibrahim M; Gordon SC; Kwo P; Rockstroh JK; Panorchan P; Miller M; Caro L; Barnard R; Hwang PM; Gress J; Quirk E; Mobashery N
    Antiviral Res; 2013 Sep; 99(3):214-20. PubMed ID: 23747481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral dynamics of persistent hepatitis C virus infection in high-sensitive reporter cells resemble patient's viremia.
    Tsai P; Lin CC; Sun HY; Lee JC; Chang TT; Young KC
    J Microbiol Immunol Infect; 2018 Aug; 51(4):446-455. PubMed ID: 28698039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of hepatitis C virus NS3/4A and secreted alkaline phosphatase to quantitate cell-cell membrane fusion mediated by severe acute respiratory syndrome coronavirus S protein and the receptor angiotensin-converting enzyme 2.
    Chou CF; Shen S; Mahadevappa G; Lim SG; Hong W; Tan YJ
    Anal Biochem; 2007 Jul; 366(2):190-6. PubMed ID: 17553448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bovine viral diarrhea virus as a surrogate model of hepatitis C virus for the evaluation of antiviral agents.
    Buckwold VE; Beer BE; Donis RO
    Antiviral Res; 2003 Sep; 60(1):1-15. PubMed ID: 14516916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DDB1 is a cellular substrate of NS3/4A protease and required for hepatitis C virus replication.
    Kang X; Chen X; He Y; Guo D; Guo L; Zhong J; Shu HB
    Virology; 2013 Jan; 435(2):385-94. PubMed ID: 23137809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of an indicator cell system for hepatitis C virus.
    Tanaka Y; Mori Y; Tani H; Abe T; Moriishi K; Kojima H; Nagano T; Okabe T; Suzuki T; Tatsumi M; Matsuura Y
    Microbiol Immunol; 2010 Apr; 54(4):206-20. PubMed ID: 20377749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-structural protein 4A of Hepatitis C virus accumulates on mitochondria and renders the cells prone to undergoing mitochondria-mediated apoptosis.
    Nomura-Takigawa Y; Nagano-Fujii M; Deng L; Kitazawa S; Ishido S; Sada K; Hotta H
    J Gen Virol; 2006 Jul; 87(Pt 7):1935-1945. PubMed ID: 16760395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of a cell-based assay system for hepatitis C virus serine protease and its primary applications.
    Mao HX; Lan SY; Hu YW; Xiang L; Yuan ZH
    World J Gastroenterol; 2003 Nov; 9(11):2474-9. PubMed ID: 14606079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Gaussia luciferase cell-based system to assess the infection of cell culture- and serum-derived hepatitis C virus.
    Koutsoudakis G; Pérez-del-Pulgar S; González P; Crespo G; Navasa M; Forns X
    PLoS One; 2012; 7(12):e53254. PubMed ID: 23300900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.